rss
J Neurol Neurosurg Psychiatry 2002;73:701-704 doi:10.1136/jnnp.73.6.701
  • Paper

Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples

  1. A Riazi1,
  2. J C Hobart1,2,
  3. D L Lamping3,
  4. R Fitzpatrick4,
  5. A J Thompson1
  1. 1Neurological Outcome Measures Unit, Institute of Neurology, London, UK
  2. 2Department of Clinical Neurosciences, Derriford Hospital, Devon, UK
  3. 3Health Services Research Unit, London School of Hygiene and Tropical Medicine, UK
  4. 4Department of Public Health and Primary Care, University of Oxford, UK
  1. Correspondence to:
 Dr J Hobart, Department of Clinical Neurosciences, Derriford Hospital, Plymouth, Devon PL8 8DH, UK;
 Jeremy.Hobart{at}phnt.swest.nhs.uk
  • Received 17 April 2002
  • Accepted 15 August 2002
  • Revised 13 May 2002

Abstract

Background and aim: The psychometric properties of rating scales are sample dependent and need evaluations in different samples. The Multiple Sclerosis Impact Scale (MSIS-29), a new patient based rating scale for multiple sclerosis (MS) was predominantly developed from a community based sample derived from the MS Society. A number of important patient characteristics of this sample remain unknown. The aim of the study was to evaluate five psychometric properties of the MSIS-29 in three hospital based samples: people admitted for rehabilitation, people admitted for intravenous corticosteroid treatment for MS relapses, and people with primary progressive MS.

Methods: People with MS were recruited from the three clinical settings. They completed several health measures. MSIS-29 data were evaluated for data quality, scaling assumptions, acceptability, reliability and validity, and compared with those from a previously reported community based study.

Results: A total of 233 people (rehabilitation =53; corticosteroids =76; primary progressive =104) completed questionnaires. In all samples, missing data were low (≤2.2%), scaling assumptions were satisfied, and reliability was high (≥0.91). Correlations between the MSIS-29 and other scales were consistent with a priori hypotheses. Findings were consistent with those from the community samples.

Conclusions: The psychometric properties of the MSIS-29 are consistent across three hospital based samples, and similar to those in the community samples. These findings further support its use as an outcome measure in different clinical settings.

Footnotes

  • Competing interests: none declared.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. Web-only Appendix

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs